Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by Georgeboy11on Jul 01, 2011 11:48am
444 Views
Post# 18788532

Could a REVERSE SPLIT be in the cards??

Could a REVERSE SPLIT be in the cards??Tis is showing no signs of any positive recovery here.  The new BOD may have no choice but to bring in a big change and do the 10:1 reverse split just to put the 'CHANGE' in motion!    Afterall, even with the new BOD, nothing has really changed except if they do the reverse split then they can start fresh!  Thoughts here?  George
Bullboard Posts